13F filing recap · Q4 2024
What did Fundsmith buy in Q4 2024?
Reported stock-position changes between this filing and the previous one.
Stock value
$23.46B
Positions
38
Estimated turnover
8.0%
Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.
Quarter in review
Fundsmith opened new positions in Medpace Holdings and Doximity, and exited Apple, Cognex, McCormick, and McDonald’s entirely. It trimmed Microsoft, Automatic Data Processing, Visa, and Fortinet, while making slight reductions to Meta Platforms, Stryker, Philip Morris International, Waters, Alphabet, Marriott, Idexx Laboratories, PepsiCo, Procter & Gamble, Mettler-Toledo, Church & Dwight, Otis Worldwide, Nike, Brown-Forman, Home Depot, Zoetis, and Mastercard.